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IN a previous paper Calcutt and Payne (1954) gave an account ofthe determi-
nation ofbenzpyrene metabolites within the four major fractions obtainable from
mouseliver homogenate. Onthatoccasion we described the discoverythat boththe
recognised primary oxidation products of 3: 4 benzpyrene are formed in the super-
natant fraction. Since then we have further examined this fraction in the attempt
to determine whether either or both these metabolites are produced in any one
subfraction.
The problem is difficult as the residue after the removal ofcell particulates has
never received the same attention as the other fractions. The material in question
undoubtedly contains a large number of proteins in solution, as has been shown
in electrophoretic studies by Sorof and Cohen (1951a, 1951b) and other authors.
Ultracentrifuge studies by the same authors were also reported and confirmed the
findings. Evidence indicating the presence of a large number of enzymes within
this fraction has also been summarised by Hogeboom, Schneider and Striebich
(1953). Obviously, with such a complex mixture the attempted separation of
chemically identifiable components would be a lengthy and tedious process. So,
as a first step in the problem, we have attempted a simple subdivision ofthe super-
natant fraction to investigate whether the substrates concerned in the formation
of the two benzpyrene metabolites can be separated.
METHODS.
Two techniques have been used for the subdivision of the supernatant, one,
an ultracentrifugation method and the other a simple salting-out process with
ammonium sulphate. Purification and estimation of the benzpyrene metabolites
were by the same methods as described in a previous paper (Calcutt and Payne,
1954).
The ultracentrifugation technique was the same as that used by Sorof, Golder
and Ott (1954) in their studies of protein bound azo dyes in rat liver supernate.
Afterpreparative angleultracentrifugation at an average force of 152,000 x g. for
7½ hours in the Spinco Ultracentrifuge these authors obtained three fractions
based upon the picture obtained by use of the cylindrical lens schlieren optical
system. The carcinogenic azo dyes were held for the most part in the fraction
representing the bulk of the albumins from rat liver.
Using the supernatant fraction obtained after removal of the cell particulate
fractions from a homogenate of mouse liver in Tyrode solution we endeavouredG. CALCUTT AND S. PAYNE
to repeat the American experiments. Ultracentrifugation under refrigerated
conditions was carried out for 71 hours, using the 26° angle head of the Spinco
Model E Ultracentrifuge at a speed of 50,740 r.p.m. (average force 152,000 x g.).
We were unable to check the sedimentation by schlieren optical methods but visual
inspection showed three distinct zones in the tubes. Under ordinary visible light
they appeared as a colourless surface layer, a faintly straw-coloured middle zone
and a deeper straw-coloured bottom layer. Examined by the illumination from
a U.V. lamp with a Woods glass filter the top layer fluoresced blue, the middle,
blue-green and the bottom greenish. Under neither condition was there any
indication of sharp demarcation of the three zones. Based on these appearances
we separated into three portions the supernatants obtained from livers taken from
mice which had been intravenously injected with colloidal benzyprene. Homo-
genisation and removal of the particulate fractions was as described earlier by
Calcutt and Payne (1954).
In a second series of experiments the supernatant fraction was split into two
subfractions by salting-out bythe addition ofanequal amount ofsaturated ammo-
nium sulphate solution. This gives an approximate separation of the globulins
from the albumins. The more efficient methods using ethanol or acetone at
lowered temperatures were precluded in the present case because of the risk of
altering the distribution of any benzpyrene or its derivatives present.
RESULTS.
For convenience we have labelled the three layers obtained in the ultracentri-
fugation experiments as: top layer, middle layer and bottom layer. These three
fractions appear to be approximate equivalents ofthe more accurately designated
fractions obtained by Sorof, Golder and Ott (1954). The distribution of benz-
pyrene and its metabolites over these fractions at intervals up to 22 hours after
introduction of the carcinogen is shown in Table I. Two interesting points arise
TABLE I.-Benzpyrene Metabolites occurring in Subfractions of Supernatant from




of mice and killing , -~
used. (hours). Top layer. Middle layer. Bottom layer
6 . 2 Bp; BpX2; BpF2 Bp; BpX,; BpFPl Bp; BpX1; BpF1
9 . 4 . Bp; BpX2 Bp; BpX1; BpX, Bp; BpF1
9 . 8 Bp; BpX2 Bp; BPX BpX Bp; BpX1; BpF, 8 . 12 . Bp; BpX2; BpF2 Bp; BpX2; BpF1 Bp; BpF,
9 . 17 BpX2 BpX2; BpF2 BpX,; BpFt
9 . 22 . BpX2; BpF2 BpX1; BpX2 Bp; BpX1; BpF1
BpF1; BpF2
All fractions were extracted in Tyrode solution.
Abbreviations used: Bp. = 3: 4 benzpyrene.
BpX1 = 8(0R1) - 9(OH)- 8,9-dihydro 3: 4 benzpyrene.
BpX2 = 8(0R1) - 9(OR2) -8,9-dihydro 3: 4 benzpyrene.
BpFL = 8(0R1) 3: 4 benzpyrene.
BpF2 = 8.OH 3: 4 benzpyrene.
here. Firstly, benzpyrene itself has been found in all three subfractions at time
intervals up to 12 hours after the injection. This is in distinct contrast to our
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previous failure to find the unchanged hydrocarbon in the supernatant fraction.
Secondly, the only metabolites in the top layer are BpX2 and its dehydration
product BpF2, whilst in the bottom layer there is only BpX1 and its breakdown
products BpF1 and BpF2. The middle layer appears as ifit were a mixture ofthe
top and bottom layers.
To test whether these distributions were truly representative of intracellular
behaviour and not artefacts arising during the separation processes a further
series of experiments was carried out. Corresponding subfractions of the super-
natant from untreated mouse liver were prepared, mixed with colloidal benzpyrene
andincubated at 37° C. inthe dark. Aftervaryingincubation periods examinations
for metabolites were carried out as previously. The findings are detailed in
Table II. These are in agreement with those from the in vivo experiments and
show that metabolism is at the sites found.
TABLE II.-Benzpyrene Derivatives found after Incubation of Colloidal Benzpyrene
with Subfractions of Mouse Liver Supernatant.
Findings.
Number of Hours of
animals. incubation. Top layer. Middle layer. Bottom layer.
9 . 4 . BpX2 BpX2; BpF1 BpF1; BpF2
8 10o BpX2 BpXl; BpX2; BpF2 BpX1; BpF1
12 15 BpX2; BpF2 BpX1; (trace) BpF1; BpF2
BpX2; (trace)
All extractions and incubations were done in Tyrode solution. Abbreviations as in Table I.
In the second series of experiments two subfractions were obtained from the
supernate by salting out. These we have designated as: precipitated fraction
(roughly representing the globulins) and soluble fraction (roughly representing the
albumins). Recovery of benzpyrene metabolites from these two fractions was
quantitatively very poor so no further subdivision was attempted. The reasons
for the bad recoveries are at present unknown. Results for a series ofexperiments
are given in Table III whilst those obtained in a corresponding series of in vitro
TABLE III.-Benzpyrene Metabolites in Mouse Liver Supernate Subfractions Salted-




of mice and killing Precipitated Soluble
used. (hours). fraction. fraction.
10 2 BpX1; BpX2 Too weak for
identification
12 5 . BpX1 BpX2
11 . 12 . BpX1; BpX2 BpX2; BpF1; BpF2
9 . 17 . BpX2; BpF1 BpX2; BpF1; BpF2
All extractions were done in Tyrode solution. Abbreviations as in Table I.
experiments are given in Table IV. Whilst no clear-cut separation is apparent it
seems that the formation ofBpX1 is mainly associated with the precipitated frac-
tion whilst BpX2 formation is essentially concentrated in the soluble fraction.
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TABLE IV.-Benzpyrene Derivatives obtained after Incubation of Mouse Liver
Supernate Subfractions with the Colloidal Hydrocarbon
Findings.
Number Incubation r
of mice time in Precipitated Soluble
used. hours. fraction. fraction.
12 2 . BpXl; BpX2 BpX2
12 . 5 . BpX,; BpF, BpX2
12 . 12 . BpX,; BpF1; BpF2 BpF1 (trace)
BpX2; BpF2
All extractions were done in Tyrode solution. Abbreviations as in Table I.
Considering the results of the two sets of experiments together it appears rea-
sonable to conclude that different substrates are involved in the formation ofBpX1
and BpX2 respectively. That interacting with benzpyrene to produce BpX1 is
probably a material having a high molecularweight and capable ofbeing salted out
of solution with 50 per cent ammonium sulphate. On the other hand BpX2
appears to arise from action involving a substance or substances oflower molecular
weights than in the previous case and also soluble in strong salt solutions.
DISCUSSION.
Assessment ofthe results detailed above inrelation to the original cell structure
is not possible until far more is known about the origin ofthe various components
of the supernatant fraction. In the case of the azo dyes, Sorof, Golder and Ott
(1954) found the bulk of bound dyestuff to be associated with the fraction they
labelled as the 3.6 proteins. Roughly, this corresponds with our "middle layer."
Quantitative estimates of the relative amounts of benzpyrene and metabolites in
our fractions have not been possible because of losses during the extraction and
purification proceedings, so direct comparison is excluded. On the other hand our
experience with respect to the recoveries obtained does not lead us to consider that
there is any predominance ofmetabolism in any one fraction.
During the present experiments unchanged benzpyrene has been found in the
three fractions obtained by ultracentrifugation, but only up to about 12 hours
after the initial injection. In earlier experiments where the supernatant fraction
was examined shortly after the death of the animal the unchanged hydrocarbon
could not be detected. In the present series because ofthe prolonged centrifuga-
tion process there has been considerable delay before the fractions have been
examined. This suggests that benzpyrene becomes bound to some component of
the living cell and is "masked" against detection by absorption spectroscopy.
Later this masked benzpyrene is freed, possibly as a consequence of some process
ofautolysis occurring withinthefraction. This corresponds with Boyland's (1949)
view that benzpyrene becomes linked in tissues "through the K region or phenan-
threne double bond and ... that the linkage is not very stable ".
The results obtained so far in these experiments have demonstrated the com-
plexity ofthe problems involved in the question of carcinogenesis by benzpyrene.
Equally, however, they have shown that future progress must depend upon
detailedstudies concerningthespecific components ofthetissues concerned. Some
such studies have been commenced.
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SUMMARY.
1. The supernatant fraction obtained from livers of mice injected with 3: 4
benzpyrene has been separated byultracentrifugation into three subfractions.
2. The fastest sedimenting fraction contained the benzpyrene derivative BpX1
and its breakdown products.
3. The slowest sedimenting fraction contained BpX2 and its breakdown
products.
4. The intermediate fraction appeared as a mixture of the other two, con-
taining BpX1 and BpX2.
5. At intervals up to 12 hours after the injection ofthe hydrocarbon unchanged
benzpyrene occurred in all three fractions.
6. Salting-out of the supernate with 50 per cent ammonium sulphate gave
results suggesting that BpX, is mainly associated with the globulin fraction whilst
BpX2 is mainly associated with the albumins.
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